Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs haloperidol vs combination therapy in agitated patients
IRCT201301199162N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of midazolam and haloperidol in agitation (3 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
midazolamhaloperidol
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT201301199162N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201301199162N8.